nach oben

Current Diabetes Reports

Erschienen in:

01.11.2019 | Diabetes Epidemiology (E Selvin and K Foti, Section Editors)

Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review

verfasst von: Yu Ting Chen, Yan Zhi Tan, Mcvin Cheen, Hwee-Lin Wee

Erschienen in: Current Diabetes Reports | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Patient-reported outcome measures (PROMs) and patient registries both play important roles in assessing patient outcomes. However, no study has examined the use of PROMs among registries involving patients with type 2 diabetes mellitus (T2DM). Our objective is twofold: first, to review the range of PROMs used in registry-based studies of patients with T2DM; second, to describe associations between these PROMs, T2DM and its complications.

Recent Findings

The International Consortium for Health Outcomes Measurement (ICHOM) Diabetes Standard Set recommended routine usage of PROMs to assess psychological well-being, diabetes distress, and depression among patients with T2DM.

Summary

A wide variety of PROMs were used among the 15 studies included in this review. Quality of life, depressive symptoms and treatment adherence were the most common aspects of T2DM that utilised PROMs for assessment. Adoption of PROMs among registries of patients with T2DM remains uncommon, non-routine and with few that are validated before use.

Nur mit Berechtigung zugänglich

Black N. Patient reported outcome measures could help transform healthcare. BMJ. 2013;346:f167. https://doi.org/10.1136/bmj.f167.CrossRefPubMed

Callahan LF. The history of patient-reported outcomes in rheumatology. Rheum Dis Clin N Am. 2016;42(2):205–17. https://doi.org/10.1016/j.rdc.2016.01.012.CrossRef

Froud R, Patel S, Rajendran D, Bright P, Bjørkli T, Buchbinder R, et al. A systematic review of outcome measures use, analytical approaches, reporting methods, and publication volume by year in low back pain trials published between 1980 and 2012: Respice, adspice, et prospice. PLoS One. 2016;11(10):e0164573-e. https://doi.org/10.1371/journal.pone.0164573.CrossRef

Weldring T, Smith SMS. Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs). Health Serv Insights. 2013;6:61–8. https://doi.org/10.4137/HSI.S11093.CrossRefPubMedPubMedCentral

Patrick, Donald L, Gordon H Guyatt, and Catherine Acquardro. Patient-Reported Outcomes. In: Cochrane Handbook For Systematic Reviews Of Interventions Version 5.1.0. The Cochrane Collaboration. 2011. https://handbook-5-1.cochrane.org/. Accessed 01 Sep 2019.

Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ (Clinical research ed). 2015;350:g7818. https://doi.org/10.1136/bmj.g7818.CrossRef

• Greenhalgh J, Dalkin S, Gooding K. Patient-reported outcome measures as a tool to support patients in raising or sharing concerns with clinicians. In: Functionality and feedback: a realist synthesis of the collation, interpretation and utilisation of patient-reported outcome measures data to improve patient care. NIHR Journals Library: Southampton; 2017. This book chapter provides a comprehensive overview of the clinical importance and benefits of PROM utilization in a wide range of health settings.

EuroQol Research Foundation. Introduction. In: EQ-5D-3L User Guide: Basic information on how to use the EQ-5D-3L instrument. 2018. https://euroqol.org/wp-content/uploads/2019/10/EQ-5D-3L-User-Guide_version-6.0.pdf. Accessed 01 Sep 2019.

Nelson EC, Dixon-Woods M, Batalden PB, Homa K, Van Citters AD, Morgan TS, et al. Patient focused registries can improve health, care, and science. BMJ (Clinical research ed). 2016;354:i3319. https://doi.org/10.1136/bmj.i3319.CrossRef

10.

National Academies of Sciences. The National Academies Collection: reports funded by National Institutes of Health. Real-World Evidence Generation and Evaluation of Therapeutics: Proceedings of a Workshop. Washington (DC): National Academies Press (US) Copyright 2017 by the National Academy of Sciences. All rights reserved.; 2017.

11.

Gliklich RE, Dreyer NA, Leavy MB. Use of patient-reported outcomes in registries. Registries for evaluating patient outcomes: a user’s guide. Rockville: Agency for Healthcare Research and Quality (US); 2014.

12.

Prodinger B, Taylor P. Improving quality of care through patient-reported outcome measures (PROMs): expert interviews using the NHS PROMs Programme and the Swedish quality registers for knee and hip arthroplasty as examples. BMC Health Serv Res. 2018;18(1):87. https://doi.org/10.1186/s12913-018-2898-z.CrossRefPubMedPubMedCentral

13.

Breckenridge K, Bekker HL, Gibbons E, van der Veer SN, Abbott D, Briançon S, et al. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant. 2015;30(10):1605–14. https://doi.org/10.1093/ndt/gfv209.CrossRefPubMedPubMedCentral

14.

Zamora NV, Christensen R, Goel N, Klokker L, Lopez-Olivo MA, Kristensen LE, et al. Critical outcomes in longitudinal observational studies and registries in patients with rheumatoid arthritis: an OMERACT Special Interest Group Report. J Rheumatol. 2017;44(12):1894–8. https://doi.org/10.3899/jrheum.161108.CrossRefPubMed

15.

Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome-a review of quality of life measurement in adults with diabetes. Diabet Med. 2009;26(4):315–27. https://doi.org/10.1111/j.1464-5491.2009.02682.x.CrossRefPubMed

16.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100.CrossRefPubMedPubMedCentral

17.

NIH National Heart, Lung and Blood Institute. Study quality assessment tools: quality assessment tool for observational cohort and cross-sectional studies. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 22 Aug 2019.

18.

Kikuchi Y, Iwase M, Fujii H, Ohkuma T, Kaizu S, Ide H, et al. Association of severe hypoglycemia with depressive symptoms in patients with type 2 diabetes: the Fukuoka Diabetes Registry. BMJ Open Diabetes Res Care. 2015;3(1):e000063. https://doi.org/10.1136/bmjdrc-2014-000063.CrossRefPubMedPubMedCentral

19.

Tsujii S, Hayashino Y, Ishii H. Diabetes distress, but not depressive symptoms, is associated with glycaemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 1). Diabet Med. 2012;29(11):1451–5. https://doi.org/10.1111/j.1464-5491.2012.03647.x.CrossRefPubMed

20.

Rathmann WK, Kuß O, Anderson D, Busch S, Hahn M, Engelhard J, et al. Increased depression symptom score in newly diagnosed type 2 diabetes patients. Psychiatry Res. 2018;261:259–63. https://doi.org/10.1016/j.psychres.2017.12.091.CrossRefPubMed

21.

Hayashino Y, Mashitani T, Tsujii S, Ishii H. Elevated levels of hs-CRP are associated with high prevalence of depression in japanese patients with type 2 diabetes: the Diabetes Distress and Care Registry at Tenri (DDCRT 6). Diabetes Care. 2014;37(9):2459–65. https://doi.org/10.2337/dc13-2312.CrossRefPubMed

22.

Hayashino Y, Okamura S, Tsujii S, Ishii H. Association between diabetes distress and all-cause mortality in Japanese individuals with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry in Tenri [DDCRT 18]). Diabetologia. 2018;61(9):1978–84. https://doi.org/10.1007/s00125-018-4657-4.CrossRefPubMed

23.

Fumagalli S, Said SA, Laroche C, Gabbai D, Boni S, Marchionni N, et al. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. Eur Heart J Cardiovasc Pharmacother. 2018;4(3):172–9. https://doi.org/10.1093/ehjcvp/pvx037.CrossRefPubMed

24.

Hayashino Y, Tsujii S, Ishii H. Association of diabetes therapy-related quality of life and physical activity levels in patients with type 2 diabetes receiving medication therapy: the Diabetes Distress and Care Registry at Tenri (DDCRT 17). Acta Diabetol. 2018;55(2):165–73. https://doi.org/10.1007/s00592-017-1080-0.CrossRefPubMed

25.

Mashitani T, Hayashino Y, Okamura S, Kitatani M, Furuya M, Iburi T, et al. Diabetes treatment-related quality of life is associated with levels of self-care activities in insulin injection among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 8). Acta Diabetol. 2015;52(4):639–47. https://doi.org/10.1007/s00592-015-0725-0.CrossRefPubMed

26.

Wasem JB, Bramlage P, Gitt AK, Binz C, Krekler M, Deeg E, et al. Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy--an analysis of the DiaRegis registry. Cardiovasc Diabetol. 2013;12:47. https://doi.org/10.1186/1475-2840-12-47.CrossRefPubMedPubMedCentral

27.

von Arx LBG, Gydesen H, Skovlund S. Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes. BMJ Open Diabetes Res Care. 2016;4(1):e000166. https://doi.org/10.1136/bmjdrc-2015-000166.CrossRef

28.

Mashitani TH, Hayashino Y, Okamura S, Kitatani M, Furuya M, Matsunaga S, et al. Patient-reported adherence to insulin regimen is associated with glycemic control among Japanese patients with type 2 diabetes: Diabetes Distress and Care Registry at Tenri (DDCRT 3). Diabetes Res Clin Pract. 2013;100(2):189–94. https://doi.org/10.1016/j.diabres.2013.03.006.CrossRefPubMed

29.

Shigaki CK, Kruse RL, Mehr D, Sheldon KM, Bin G, Moore C, et al. Motivation and diabetes self-management. Chronic Ill. 2010;6(3):202–14. https://doi.org/10.1177/1742395310375630.CrossRef

30.

Woo V, Bell A, Clement M, Noronha L, Tsoukas MA, Camacho F, et al. CANadian CAnagliflozin REgistry: patient-reported outcomes of canagliflozin in the treatment of type 2 diabetes mellitus in canadian clinical practice. Can J Diabetes. 2019. https://doi.org/10.1016/j.jcjd.2019.04.004.CrossRefPubMed

31.

Berkowitz SA, Karter AJ, Lyles CR, Liu JY, Schillinger D, Adler NE, et al. Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE). J Health Care Poor Underserved. 2014;25(2):478–90. https://doi.org/10.1353/hpu.2014.0106.CrossRefPubMedPubMedCentral

32.

Philpot LM, Barnes SA, Brown RM, Austin JA, James CS, Stanford RH, et al. Barriers and benefits to the use of patient-reported outcome measures in routine clinical care: a qualitative study. Am J Med Qual. 2018;33(4):359–64. https://doi.org/10.1177/1062860617745986.CrossRefPubMed

33.

• International Consortium for Health Outcomes Measurement. Type 1 and Type2 Diabetes in Adults: DATA COLLECTION REFERENCE GUIDE 2019. This report identified a core, standard set of outcomes which matter most to people with diabetes, and recommended psychological well-being, diabetes distress and depression to be routinely assessed among patients with diabetes.

34.

Tang TS, Yusuf FLA, Polonsky WH, Fisher L. Assessing quality of life in diabetes: II - deconstructing measures into a simple framework. Diabetes Res Clin Pract. 2017;126:286–302. https://doi.org/10.1016/j.diabres.2016.10.007.CrossRefPubMed

35.

Woodcock AJ, Julious SA, Kinmonth AL, Campbell MJ. Problems with the performance of the SF-36 among people with type 2 diabetes in general practice. Qual Life Res. 2001;10(8):661–70.CrossRefPubMed

36.

Zettler ME, SANDOVAL R. Patient-reported outcome labeling for antidiabetic agents approved in the United States, 2011–2017. Diabetes. 2018;67(Supplement 1):1284. https://doi.org/10.2337/db18-1284-P.CrossRef

37.

U.S. Department of Health & Human Services. Registry Of Patient Registries. Agency For Healthcare Research And Quality. 2019. https://www.ahrq.gov/ropr/index.html. Accessed 29 Aug 2019.

38.

Haverman L, van Oers HA, van Muilekom MM, Grootenhuis MA. Options for the Interpretation of and recommendations for acting on different PROMs in daily clinical practice using KLIK. Med Care. 2019;57(Suppl 5 Suppl 1):S52–s8. https://doi.org/10.1097/mlr.0000000000001061.CrossRefPubMed

39.

Grossman LV, Feiner SK, Mitchell EG, Masterson Creber RM. Leveraging patient-reported outcomes using data visualization. Appl Clin Inform. 2018;9(3):565–75. https://doi.org/10.1055/s-0038-1667041.CrossRefPubMedPubMedCentral

40.

Radloff LS. The CES-D Scale: A Self-Report Depression Scale for research in the general population. Appl Psychol Meas. 1977;1(3):385–401.CrossRef

41.

Jahn R, Baumgartner JS, van den Nest M, Friedrich F, Alexandrowicz RW, Wancata J. Criterion Validity of the German Version of the CES-D in the General Population. Psychiatr Prax. 2018;45(8):434–42. https://doi.org/10.1055/a-0584-9803.CrossRefPubMed

42.

Wada K, Tanaka K, Theriault G, Satoh T, Mimura M, Miyaoka H, et al. Validity of the Center for Epidemiologic Studies Depression Scale as a screening instrument of majosr depressive disorder among Japanese workers. Am J Ind Med. 2007;50(1):8–12. https://doi.org/10.1002/ajim.20403.CrossRefPubMed

43.

RAND Health Care. 36-Item Short Form Survey (SF-36) Scoring Instructions. https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html. Accessed 21 Aug 2019.

44.

Ware JEKM, Dewey JE, Gandek B. How to score and interpret single-item health status measures: a manual for users of the SF-8 Health Survey. Boston: QualityMetric, Inc; 2001.

45.

Tokuda Y, Okubo T, Ohde S, Jacobs J, Takahashi O, Omata F, et al. Assessing items on the SF-8 Japanese version for health-related quality of life: a psychometric analysis based on the nominal categories model of item response theory. Value Health. 2009;12(4):568–73. https://doi.org/10.1111/j.1524-4733.2008.00449.x.CrossRefPubMed

46.

Konerding U, Elkhuizen SG, Faubel R, Forte P, Malmström T, Pavi E, et al. The validity of the EQ-5D-3L items: an investigation with type 2 diabetes patients from six European countries. Health Qual Life Outcomes. 2014;12:181. https://doi.org/10.1186/s12955-014-0181-5.CrossRefPubMedPubMedCentral

47.

Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res. 1999;8:79–91.CrossRefPubMed

48.

Wee HL, Tan CE, Goh SY, Li SC. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) Questionnaire in Patients with Diabetes in a Multi-Ethnic Asian Country. PharmacoEconomics. 2006;24(7):673–82.CrossRefPubMed

49.

IPAQ Group. Protocol for IPAQ Short Form. In: Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ) – Short and Long Forms. International Physical Activity Questionnaire. 2005. https://sites.google.com/site/theipaq/scoring-protocol. Accessed 24 Aug 2019.

50.

Tomioka K, Iwamoto J, Saeki K, Okamoto N. Reliability and validity of the International Physical Activity Questionnaire (IPAQ) in elderly adults: the Fujiwara-kyo Study. J Epidemiol. 2011;21(6):459–65. https://doi.org/10.2188/jea.je20110003.CrossRefPubMedPubMedCentral

51.

Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498–504.CrossRefPubMed

52.

Spitzer RL WJ, Kroenke K. Coding and Scoring. In: Instruction Manual: Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures. Patient Health Questionnaire (PHQ) Screeners. n.d. https://www.phqscreeners.com/select-screener. Accessed 16 Aug 2019.

53.

Doi S, Ito M, Takebayashi Y, Muramatsu K, Horikoshi M. Factorial validity and invariance of the Patient Health Questionnaire (PHQ)-9 among clinical and non-clinical populations. PLoS One. 2018;13(7):e0199235. https://doi.org/10.1371/journal.pone.0199235.CrossRefPubMedPubMedCentral

54.

Ishii H. Psycho-behavioral problems in diabetes treatment. J Jpn Diab Soc. 2000;43(1):13–6.

55.

Traina SB, Colwell HH, Crosby RD, Mathias SD. Pragmatic measurement of health satisfaction in people with type 2 diabetes mellitus using the Current Health Satisfaction Questionnaire. Patient Relat Outcome Meas. 2015;6:103–15. https://doi.org/10.2147/prom.S79368.CrossRefPubMedPubMedCentral

56.

Traina SB, McQuarrie K, Barrett A, DiBenedetti D, McLeod L. Content Validity of the Current Health Satisfaction Questionnaire (Ches-Q) Among People Living with Type 2 Diabetes Mellitus (T2 dm) and Comorbid Chronic Kidney Disease (Ckd). Value Health. 2015;18(7):A710–A1. https://doi.org/10.1016/j.jval.2015.09.2675.CrossRef

57.

Arribas F, Ormaetxe JM, Peinado R, Perulero N, Ramirez P, Badia X. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. Europace. 2010;12(3):364–70. https://doi.org/10.1093/europace/eup421.CrossRefPubMed

58.

Ishii H. Development and psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire. J Med Econ. 2012;15(3):556–63. https://doi.org/10.3111/13696998.2012.665111.CrossRefPubMed

59.

Ishii H, Suzaki Y, Miyata Y, Matsui S. Randomized multicenter evaluation of quality of life and treatment satisfaction in type 2 diabetes patients receiving once-weekly trelagliptin versus a daily dipeptidyl peptidase-4 inhibitor. Diabetes Ther. 2019;10(4):1369–80. https://doi.org/10.1007/s13300-019-0643-1.CrossRefPubMedPubMedCentral

60.

Ishii H, Kim HR, Crawford B. The revalidation of the diabetes treatment-related quality-of-life (DTR-QOL) questionnaire in Japan. Diabetol Int. 2019;10(2):93–101. https://doi.org/10.1007/s13340-018-0371-1.CrossRefPubMed

61.

Ji L, Zhang P, Weng J, Lu J, Guo X, Jia W, et al. Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China--study design and baseline characteristics. Diabetes Technol Ther. 2015;17(10):735–44. https://doi.org/10.1089/dia.2015.0054.CrossRefPubMed

62.

Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50. https://doi.org/10.2337/diacare.23.7.943.CrossRefPubMed

63.

Levesque CS, Williams GC, Elliot D, Pickering MA, Bodenhamer B, Finley PJ. Validating the theoretical structure of the Treatment Self-Regulation Questionnaire (TSRQ) across three different health behaviors. Health Educ Res. 2006;22(5):691–702. https://doi.org/10.1093/her/cyl148.CrossRefPubMed

64.

RAND Health Care. Social Support Survey Instrument Scoring Instructions. n.d. https://www.rand.org/health-care/surveys_tools/mos/social-support/scoring.html. Accessed 21 Aug 2019.

65.

Hayashino Y, Tsujii S, Ishii H. High frequency of non-nocturnal hypoglycemia was associated with poor sleep quality measure by Pittsburg Sleep Quality Index in patients with diabetes receiving insulin therapy: Diabetes Distress and Care Registry at Tenri (DDCRT 4). Exp Clin Endocrinol Diabetes. 2013;121(10):628–34. https://doi.org/10.1055/s-0033-1355424.CrossRefPubMed

66.

Kobayashi S, Honda S, Murakami K, Sasaki S, Okubo H, Hirota N, et al. Both comprehensive and brief self-administered diet history questionnaires satisfactorily rank nutrient intakes in Japanese adults. J Epidemiol. 2012;22(2):151–9. https://doi.org/10.2188/jea.je20110075.CrossRefPubMedPubMedCentral

67.

Merola A, Sturchio A, Hacker S, Serna S, Vizcarra JA, Marsili L, et al. Technology-based assessment of motor and nonmotor phenomena in Parkinson disease. Expert Rev Neurother. 2018;18(11):825–45. https://doi.org/10.1080/14737175.2018.1530593.CrossRefPubMed

Titel: Patient-Reported Outcome Measures in Registry-Based Studies of Type 2 Diabetes Mellitus: a Systematic Review
verfasst von: Yu Ting Chen
Yan Zhi Tan
Mcvin Cheen
Hwee-Lin Wee
Publikationsdatum: 01.11.2019
Verlag: Springer US
Erschienen in: Current Diabetes Reports / Ausgabe 11/2019
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI: https://doi.org/10.1007/s11892-019-1265-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Diabetes and Disasters: Recent Studies and Resources for Preparedness

Correction to: Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition

Emerging Concepts in the Treatment of Diabetic Retinopathy

Risk of Type 1 Diabetes in the Offspring Born through Elective or Non-elective Caesarean Section in Comparison to Vaginal Delivery: a Meta-Analysis of Observational Studies

Glycemic Management in the Operating Room: Screening, Monitoring, Oral Hypoglycemics, and Insulin Therapy

The Genetic Contribution to Type 1 Diabetes